These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 39103002)
1. Improved therapeutic index of the liposomal docetaxel-glutathione prepared by active click loading. Jin X; Zhou Q; Cao L; Tie X; Ouyang H; Pan X; Diao J; Zhu Y; Li Y; Liu X; Zheng Y Eur J Pharm Biopharm; 2024 Oct; 203():114435. PubMed ID: 39103002 [TBL] [Abstract][Full Text] [Related]
2. Co-Delivery of Docetaxel and Curcumin Functionalized Mixed Micelles for the Treatment of Drug-Resistant Breast Cancer by Oral Administration. Dian C; Qian Z; Ran M; Yan X; Dian L Int J Nanomedicine; 2024; 19():8603-8620. PubMed ID: 39188859 [TBL] [Abstract][Full Text] [Related]
3. Optimization of Docetaxel Loading Conditions in Liposomes: proposing potential products for metastatic breast carcinoma chemotherapy. Vakili-Ghartavol R; Rezayat SM; Faridi-Majidi R; Sadri K; Jaafari MR Sci Rep; 2020 Mar; 10(1):5569. PubMed ID: 32221371 [TBL] [Abstract][Full Text] [Related]
4. Docetaxel in combination with metformin enhances antitumour efficacy in metastatic breast carcinoma models: a promising cancer targeting based on PEGylated liposomes. Vakili-Ghartavol R; Mehrabian A; Mirzavi F; Rezayat SM; Mashreghi M; Farhoudi L; Kharrazi S; Sadri K; Jaafari MR J Pharm Pharmacol; 2022 Sep; 74(9):1307-1319. PubMed ID: 35833585 [TBL] [Abstract][Full Text] [Related]
5. Comparison of two kinds of docetaxel-vitamin E prodrugs: In vitro evaluation and in vivo antitumor activity. Wang J; Xue P; Zhou J; Li L; Xu L; Wang Y Int J Pharm; 2016 May; 505(1-2):352-60. PubMed ID: 27085643 [TBL] [Abstract][Full Text] [Related]
6. GE11 peptide-conjugated nanoliposomes to enhance the combinational therapeutic efficacy of docetaxel and siRNA in laryngeal cancers. Xu WW; Liu DY; Cao YC; Wang XY Int J Nanomedicine; 2017; 12():6461-6470. PubMed ID: 28919747 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of lipid emulsions of docetaxel-linoleic acid conjugate in breast cancer. Zhang T; Li M; Yang R; Zhang D; Guan J; Yu J; Yang B; Zhang H; Zhang S; Liu D; Wang Y Int J Pharm; 2018 Jul; 546(1-2):61-69. PubMed ID: 29763687 [TBL] [Abstract][Full Text] [Related]
9. Crafting Docetaxel-Loaded Albumin Nanoparticles Through a Novel Thermal-Driven Self-Assembly/Microfluidic Combination Technology: Formulation, Process Optimization, Stability, and Bioavailability. Du J; Shi LL; Jiang WW; Liu XA; Wu XH; Huang XX; Huo MW; Shi LZ; Dong J; Jiang X; Huang R; Cao QR; Zhang W Int J Nanomedicine; 2024; 19():5071-5094. PubMed ID: 38846644 [TBL] [Abstract][Full Text] [Related]
10. Docetaxel-loaded RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes: Drug release, cytotoxicity, and antitumor efficacy. Yoon HY; Kwak SS; Jang MH; Kang MH; Sung SW; Kim CH; Kim SR; Yeom DW; Kang MJ; Choi YW Int J Pharm; 2017 May; 523(1):229-237. PubMed ID: 28341149 [TBL] [Abstract][Full Text] [Related]
11. Drug-interactive mPEG- Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299 [TBL] [Abstract][Full Text] [Related]
12. PEG-conjugated triacontanol micelles as docetaxel delivery systems for enhanced anti-cancer efficacy. Lu X; Fang M; Yang Y; Dai Y; Xu J; Zhao D; Lu Y; Chen X; Lu S; Li N Drug Deliv Transl Res; 2020 Feb; 10(1):122-135. PubMed ID: 31444736 [TBL] [Abstract][Full Text] [Related]
13. Enhanced antitumor effect on intrapulmonary tumors of docetaxel lung-targeted liposomes in a rabbit model of VX2 orthotopic lung cancer. Wang L; Li R; Che K; Liu Z; Xiang S; Li M; Yu Y Sci Rep; 2017 Aug; 7(1):10069. PubMed ID: 28855665 [TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization, and pharmacodynamics of thermosensitive liposomes containing docetaxel. Zhang H; Gong W; Wang ZY; Yuan SJ; Xie XY; Yang YF; Yang Y; Wang SS; Yang DX; Xuan ZX; Mei XG J Pharm Sci; 2014 Jul; 103(7):2177-2183. PubMed ID: 24846075 [TBL] [Abstract][Full Text] [Related]
15. RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells. Lee SG; Kim CH; Sung SW; Lee ES; Goh MS; Yoon HY; Kang MJ; Lee S; Choi YW Int J Nanomedicine; 2018; 13():3263-3278. PubMed ID: 29910614 [TBL] [Abstract][Full Text] [Related]
16. Docetaxel loaded mPEG-PLA nanoparticles for sarcoma therapy: preparation, characterization, pharmacokinetics, and anti-tumor efficacy. Chen J; Ning E; Wang Z; Jing Z; Wei G; Wang X; Ma P Drug Deliv; 2021 Dec; 28(1):1389-1396. PubMed ID: 34180752 [TBL] [Abstract][Full Text] [Related]
17. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy. Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783 [TBL] [Abstract][Full Text] [Related]
18. Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells. Kim CH; Kang TH; Kim BD; Lee TH; Yoon HY; Goo YT; Choi YS; Kang MJ; Choi YW Int J Pharm; 2020 Jun; 583():119393. PubMed ID: 32376445 [TBL] [Abstract][Full Text] [Related]
19. A novel monomethoxy polyethylene glycol-polylactic acid polymeric micelles with higher loading capacity for docetaxel and well-reconstitution characteristics and its anti-metastasis study. Li Y; Yang F; Chen W; Liu J; Huang W; Jin M; Gao Z Chem Pharm Bull (Tokyo); 2012; 60(9):1146-54. PubMed ID: 22976323 [TBL] [Abstract][Full Text] [Related]
20. Docetaxel prodrug liposomes for tumor therapy: characterization, in vitro and in vivo evaluation. Ren G; Liu D; Guo W; Wang M; Wu C; Guo M; Ai X; Wang Y; He Z Drug Deliv; 2016 May; 23(4):1272-81. PubMed ID: 26965023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]